Skip to main content
Bio-Gate AG logo

Bio-Gate AG — Investor Relations & Filings

Ticker · BIG1 ISIN · DE000BGAG981 LEI · 391200G5LKTIOTZOXP90 F Manufacturing
Open in API
Filings indexed 242 across all filing types
Latest filing 2025-02-26 Earnings Release
Country DE Germany
Listing F BIG1

About Bio-Gate AG

https://www.bio-gate.de/en/

Bio-Gate AG is a provider of innovative technologies and customized solutions for health and hygiene, specializing in antimicrobial and antiviral strategies. The company enhances materials and products by incorporating its unique silver-based technologies, such as MicroSilver BG™. Key applications are concentrated in the medical technology sector, including the coating of medical implants and wound dressings to prevent infections. The company's technologies are also utilized in derma-cosmetics and veterinary care products. Furthermore, Bio-Gate provides solutions for industrial and consumer goods, imparting antimicrobial properties to items like paints, coatings, plastics, and textiles.

Recent filings

Filing Released Lang Actions
Bio-Gate AG: Medizinisches CBD-Muskelpflege-Gel von Bio-Gate erhalt in klinischer Studie Testergebnis sehr gut
Earnings Release Classification · 99% confidence The document is a press release dated February 26, 2025, announcing positive clinical study results ("sehr gut") for a medical CBD muscle care gel from Bio-Gate AG. It details the study, the benefits of CBD, and the strategic implications for the company's Dermocosmetics and Wound Care business fields. This type of announcement, focusing on a specific operational or product development milestone rather than comprehensive financial results (like 10-K or IR) or management changes (MANG), is best classified as a general corporate news release. Since there is no specific category for 'Product/Study Result Announcement' and it is not a formal regulatory filing like a 10-K or a short announcement pointing to an attached report (RPA), the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general category for miscellaneous corporate announcements distributed via services like EQS News. FY 2025
2025-02-26 German
Bio-Gate bringt uber Partner weitere Produktlinie zum Schutz von Haut- und Hufarealen bei Pferden auf den Markt
Regulatory Filings Classification · 100% confidence The document is a press release dated February 20, 2025, announcing a new product line for horses and providing preliminary financial figures for the second half of 2024, including revenue and net loss figures. The text explicitly mentions 'Vorläufige Zahlen belegen verbessertes 2. Halbjahr 2024' (Preliminary figures prove improved second half of 2024) and provides specific, albeit unaudited, financial data for H2 2024 and FY 2024. This structure—announcing operational news alongside preliminary financial highlights for a recent period—is characteristic of an Earnings Release (ER). It is not a comprehensive Annual Report (10-K) or a detailed Interim Report (IR), nor is it a transcript (CT) or a formal management discussion (MDA). It is the initial announcement of results.
2025-02-21 German
Bio-Gate bringt uber Partner weitere Produktlinie zum Schutz von Haut- und Hufarealen bei Pferden auf den Markt
Earnings Release Classification · 99% confidence The document is a press release dated February 20, 2025, announcing the launch of a new product line for horses and providing preliminary financial figures for the second half of 2024. The key phrases are 'PRESSEINFORMATION', 'Produktlinie zum Schutz von Haut- und Hufarealen bei Pferden auf den Markt', and 'Vorläufige Zahlen belegen verbessertes 2. Halbjahr 2024'. This content structure—announcing business news (product launch) alongside preliminary financial highlights—is characteristic of an Earnings Release (ER), which provides the initial announcement of periodical financial results, often before the full quarterly or annual report. It is not the full comprehensive report (IR or 10-K), nor is it a transcript (CT) or a formal regulatory filing like a DVA or DIRS. Since it contains key financial updates ('Umsatz im zweiten Halbjahr demnach 3,6 Mio. Euro', 'Nettoergebnis lag bei -0,5 Mio. Euro'), ER is the most appropriate classification over a general RNS. FY 2024
2025-02-20 German
Bio-Gate bringt uber Partner weitere Produktlinie zum Schutz von Haut- und Hufarealen bei Pferden auf den Markt
Earnings Release Classification · 99% confidence The document is a press release dated February 20, 2025, announcing a new product line for horses and providing preliminary financial figures for the second half of 2024, including revenue and net loss figures. The text explicitly mentions 'Vorläufige Zahlen belegen verbessertes 2. Halbjahr 2024' (Preliminary figures prove improved second half of 2024) and provides specific, albeit unaudited, financial data for H2 2024 and FY 2024. This structure—announcing operational news alongside preliminary financial highlights for a recent period—is characteristic of an Earnings Release (ER). It is not a comprehensive Annual Report (10-K) or a detailed Interim Report (IR), nor is it a transcript (CT) or a formal management discussion (MDA). It is the initial announcement of results. FY 2024
2025-02-20 German
Bio-Gate bietet mit HyProtectTMTechnologie wirksame Infektionspravention in der Human-Medizin
Regulatory Filings Classification · 95% confidence The document is a press release dated December 16, 2024, originating from Bio-Gate AG, distributed via EQS News. It announces a significant operational update: the start of a clinical study for CE approval of HyProtectTM-coated implants and highlights the technology's effectiveness against infections. The content focuses on business development, clinical progress, and market potential, rather than presenting periodic financial results (like 10-K or IR) or official voting outcomes. It is a general corporate news announcement regarding a specific business development. Since it is not a formal regulatory filing like a 10-K, a quarterly report (IR), or a specific announcement like a dividend (DIV) or management change (MANG), and it is not merely announcing the publication of another report (RPA), the most appropriate general category for significant, non-financial, non-management-specific corporate news distributed via a news service is 'Regulatory Filings' (RNS) as a broad corporate announcement category, although 'LTR' (Legal Proceedings Report) or 'CAP' (Capital/Financing Update) are not applicable. Given the nature of the announcement (a business/technology update distributed as 'Corporate News'), RNS serves as the best fit among the provided options for a general, non-periodic, non-specific corporate disclosure.
2024-12-17 German
Bio-Gate bietet mit HyProtectTMTechnologie wirksame Infektionspravention in der Human-Medizin
Regulatory Filings Classification · 100% confidence The document is a press release dated December 16, 2024, originating from Bio-Gate AG, distributed via EQS News. It announces a significant operational update: the start of a clinical study for CE approval of HyProtectTM-coated implants and highlights the technology's effectiveness against infections. The content focuses on business development, clinical progress, and market potential, rather than presenting periodic financial results (like 10-K or IR) or official voting outcomes. It is a general corporate news announcement regarding a specific business development. Since it is not a formal regulatory filing like a 10-K, a quarterly report (IR), or a specific announcement like a dividend (DIV) or management change (MANG), and it is not merely announcing the publication of another report (RPA), the most appropriate general category for significant, non-financial, non-management-specific corporate news distributed via a news service is 'Regulatory Filings' (RNS) as a broad corporate announcement category, although 'LTR' (Legal Proceedings Report) or 'CAP' (Capital/Financing Update) are not applicable. Given the nature of the announcement (a business/technology update distributed as 'Corporate News'), RNS serves as the best fit among the provided options for a general, non-periodic, non-specific corporate disclosure.
2024-12-16 German

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.